Global Asthma Preventive Market Size, Share & Trends Analysis, By Type (Sodium Cromolyn and Prednisolone), By Application (Children and Adult), Forecast (2022-2028)

The global asthma preventive market is anticipated to grow at a significant CAGR during the forecast period (2022- 2028).  Asthma is a condition in which airways narrow and swell and may produce extra mucus. Asthma is a chronic disease of the air passages of the lungs which inflames and narrows them, causing continuous attacks of breathlessness. Asthma is a very serious disease and thus requires the administration of treatment drugs for the same. Reasons for asthma include air pollution, tobacco, smoke, chemical irritants, indoor and outdoor allergens. There is a significant rise in asthma cases, due to a rise in air pollution in a high number of urban, as well as, rural areas globally. There is a considerable increase in the number of smokers, which induces the symptoms of asthma. The rise in industrialization has also led to an increase in the number of asthma cases, which will drive the market globally during the forecast period. With is the introduction of low-cost and effective therapeutics is also the major factor that is anticipated to drive the growth of the market.

Some major players companies in the market include Pfizer Inc, Abbott Laboratories, Novartis International AG, and F. Hoffmann La Roche Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered-
    • By Type
    • By Application
  • Regions Covered-
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
  • Competitive Landscape- Pfizer Inc, Abbott Laboratories, Novartis International AG, and F. Hoffmann La Roche Ltd., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?
    • Deviation from the pre-COVID-19 forecast
    • Most affected region and segment
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Asthma Preventive Market Report by Segment

By Type

  • Sodium Commonly
  • Prednisolone

By Application

  • Children
  • Adult

Global Asthma Preventive Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific

Rest of the World

  • Latin America
  • Middle East & Africa

The report will be delivered within 48-72 hours after payment confirmation